130 related articles for article (PubMed ID: 21983165)
1. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kishimoto T; Miyazaki T; Nishino A; Nakajima N; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Yatomi Y; Daida H
Clin Chim Acta; 2012 Jan; 413(1-2):207-12. PubMed ID: 21983165
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
[TBL] [Abstract][Full Text] [Related]
3. Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kurano M; Kishimoto T; Yanagisawa N; Ogita M; Miyazaki T; Nishino A; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Daida H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):192-7. PubMed ID: 23664202
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome.
Ren MY; Sui SJ; Zhang Y; Xu FY; Xu XQ; Zhao JJ; Du YM; Liu WH
Acta Cardiol; 2008 Oct; 63(5):615-22. PubMed ID: 19014006
[TBL] [Abstract][Full Text] [Related]
5. Increased circulating soluble LR11 in patients with acute coronary syndrome.
Ogita M; Miyauchi K; Dohi T; Tsuboi S; Miyazaki T; Yokoyama T; Yokoyama K; Shimada K; Kurata T; Jiang M; Bujo H; Daida H
Clin Chim Acta; 2013 Jan; 415():191-4. PubMed ID: 23127357
[TBL] [Abstract][Full Text] [Related]
6. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity.
Hosogaya S; Yatomi Y; Nakamura K; Ohkawa R; Okubo S; Yokota H; Ohta M; Yamazaki H; Koike T; Ozaki Y
Ann Clin Biochem; 2008 Jul; 45(Pt 4):364-8. PubMed ID: 18583620
[TBL] [Abstract][Full Text] [Related]
7. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
Yatomi Y
Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
[TBL] [Abstract][Full Text] [Related]
8. Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay.
Ohkawa R; Kurano M; Sakai N; Kishimoto T; Nojiri T; Igarashi K; Hosogaya S; Ozaki Y; Dohi T; Miyauchi K; Daida H; Aoki J; Okubo S; Ikeda H; Tozuka M; Yatomi Y
Sci Rep; 2018 Mar; 8(1):4725. PubMed ID: 29549312
[TBL] [Abstract][Full Text] [Related]
9. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
Granér M; Tikkanen E; Rimpilä O; Tikkanen H; Ripatti S; Lokki ML; Nieminen MS; Taskinen MR; Sinisalo J
Ann Med; 2013 Jun; 45(4):322-7. PubMed ID: 23651064
[TBL] [Abstract][Full Text] [Related]
11. [The Laboratory Medicine of Lipid Mediators].
Yatomi Y
Rinsho Byori; 2015 Oct; 63(10):1183-6. PubMed ID: 26897854
[TBL] [Abstract][Full Text] [Related]
12. Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.
Michalczyk A; Dołęgowska B; Heryć R; Chlubek D; Safranow K
Lipids Health Dis; 2019 Apr; 18(1):85. PubMed ID: 30947711
[TBL] [Abstract][Full Text] [Related]
13. [Plasma matrix metalloproteinases-2 and -9 levels are elevated in patients with acute coronary syndrome and coronary chronic total occlusion].
Tang QD; Wu PS; Hou YQ; Huang Z; Zhou ZJ; Guo ZG; Xiu JC; Wang YG
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1004-7. PubMed ID: 19460733
[TBL] [Abstract][Full Text] [Related]
14. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids.
Nakamura K; Kishimoto T; Ohkawa R; Okubo S; Tozuka M; Yokota H; Ikeda H; Ohshima N; Mizuno K; Yatomi Y
Anal Biochem; 2007 Aug; 367(1):20-7. PubMed ID: 17568554
[TBL] [Abstract][Full Text] [Related]
16. Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors.
Tokumura A; Tominaga K; Yasuda K; Kanzaki H; Kogure K; Fukuzawa K
Cancer; 2002 Jan; 94(1):141-51. PubMed ID: 11815970
[TBL] [Abstract][Full Text] [Related]
17. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
Kobayashi N; Takano M; Hata N; Kume N; Yamamoto M; Yokoyama S; Shinada T; Tomita K; Shirakabe A; Otsuka T; Seino Y; Mizuno K
Int J Cardiol; 2013 Oct; 168(4):3217-23. PubMed ID: 23632121
[TBL] [Abstract][Full Text] [Related]
18. The different association of epicardial fat with coronary plaque in patients with acute coronary syndrome and patients with stable angina pectoris: analysis using integrated backscatter intravascular ultrasound.
Harada K; Harada K; Uetani T; Kataoka T; Takeshita M; Kunimura A; Takayama Y; Shinoda N; Kato B; Kato M; Marui N; Ishii H; Matsubara T; Amano T; Murohara T
Atherosclerosis; 2014 Oct; 236(2):301-6. PubMed ID: 25117765
[TBL] [Abstract][Full Text] [Related]
19. Circulating cytokines in relation to the extent and composition of coronary atherosclerosis: results from the ATHEROREMO-IVUS study.
Battes LC; Cheng JM; Oemrawsingh RM; Boersma E; Garcia-Garcia HM; de Boer SP; Buljubasic N; Mieghem NA; Regar E; Geuns RJ; Serruys PW; Akkerhuis KM; Kardys I
Atherosclerosis; 2014 Sep; 236(1):18-24. PubMed ID: 25003948
[TBL] [Abstract][Full Text] [Related]
20. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
